“... all disciplines required to serve you in M&A. They are practical and don't get lost in unnecessary detail.”
Legal 500, Commercial, corporate and M&A
A leading independent international law firm.
We offer bespoke legal solutions to multinational corporations, government agencies, international trade associations, and law firms around the world.
Our clients view us as the ‘go to’ firm for our areas of expertise.
Our people appreciate our intellectually stimulating and supportive working environment.
Our aim is to exceed expectations, providing clients with first-class legal and strategic advice and our people with an exceptional, inclusive workplace where they can develop and thrive.
VBB culture is unlike any other law firm I have encountered; it fosters an atmosphere where talent and camaraderie go hand in hand.
Diego Serré, Associate
->
News & insights
1 min
read
read
Briefings
European Commission issues new draft merger control guidelines, launches public consultation
30 April 2026
1 min
read
read
Briefings
First CMA Consumer Fine Shows Commitment to Enforce New Regime
29 April 2026
1 min
read
read
Briefings
EU circular economy package: short-term measures targeting plastics crisis and market distortions
29 April 2026
1 min
read
read
Briefings
EU Commission disqualifies Chinese supplier in its first FSR procurement decision
28 April 2026
2 min
read
read
News
EU Foreign Subsidies Regulation (FSR): VBB acts in first challenge to inspections and requests to access digital material
23 April 2026
6 min
read
read
News
Report Calls for Strengthening of Rules Governing Abuse of Economic Dependence
15 April 2026
1 min
read
read
News
VBB secures zero duty for Taekwang Industrial Co. in EU anti-dumping investigation on imports of PTA from Korea
10 April 2026
1 min
read
read
News
Belgium: Merger control - New means and ambitions of the Competition Authority
8 April 2026
2 min
read
read
Briefings
Belgian Competition Authority Publishes Guidelines on Sustainability Agreements
7 April 2026
1 min
read
read
Briefings
Court of Justice of European Union Clarifies Scope of Officinal Formula Exemption Under EU Medicinal Product Law
25 March 2026
